Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
Company Description (as filed with the SEC)
Venaxis, Inc. (the “Company” or also “we”, “us” or “our”) is focused on advancing products that addresses unmet human diagnostic needs. Venaxis was formed in August 2000 as a Colorado corporation to produce purified proteins for diagnostic applications. To date, we have leveraged our science and technology to advance development of our APPY1 product candidate, and developed animal health-related assets, including intellectual property. In 2012, we out-licensed these animal health-related assets as described below. During December 2012, the Company’s name was changed to Venaxis, Inc., from AspenBio Pharma, Inc. Our business strategy is to focus on products and technologies we believe have attractive worldwide markets and significant product margin potential. Our acute appendicitis test, APPY1, our current primary focus, meets these objectives. ... More ...
|Annual EPS Est:||$-1.84|
|Quarterly EPS Est:||-0.15|